Citations Report
Clinical Schizophrenia & Related Psychoses : Citations & Metrics Report
Articles published in Clinical Schizophrenia & Related Psychoses have been cited by esteemed scholars and scientists all around the world. Clinical Schizophrenia & Related Psychoses has got h-index 41, which means every article in Clinical Schizophrenia & Related Psychoses has got 41 average citations.
Following are the list of articles that have cited the articles published in Clinical Schizophrenia & Related Psychoses.
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Year wise published articles |
105 | 141 | 28 | 8 | 28 |
Year wise citations received |
543 | 553 | 590 | 563 | 587 |
| Journal total citations count | 6601 |
| Journal Impact Factor | 6.49 |
| Journal 5 years Impact Factor | 12.17 |
| Journal CiteScore | 11.19 |
| Journal h-index | 41 |
| Journal h-index since 2016 | 26 |
Javitt, Daniel C. "Glutamate and schizophrenia: from theory to treatment implications." Psychiatric Times 31, no. 9 (2014): 49-49. |
|
Challa, Feyissa, Daniel Seifu, Meron Seleshi, Tigist Getahun, Desta Kassa, Melkam Alemayehu, Miraf Mesfin, Yimtubezinash Woldeamanuel, Abebaw Fekadu, and Zeleke Geto. "Inflammatory Markers in Patients With Treatment-Resistant Schizophrenia in Ethiopia: A Comparative Study." (2021). |
|
Levi, Linda, Jacob S. Ballon, and Joshua T. Kantrowitz. "Investigational treatments for cognitive impairment in schizophrenia: the authors examine the landscape of drug and nondrug therapies under active investigation for cognitive impairment in schizophrenia." Current Psychiatry 12, no. 9 (2013): 38-44. |
|
Challa, Feyissa, Daniel Seifu, Meron Sileshi, Tigist Getahun, Zeleke Geto, Desta Kassa, Melkam Alemayehu, Miraf Mesfin, Abebaw Fekadu, and Yimtubezinash Woldeamanuel. "Serum level of high sensitive C-reactive protein and IL? 6 markers in patients with treatment-resistant schizophrenia in Ethiopia: a comparative study." BMC psychiatry 21, no. 1 (2021): 1-8. |
|
Guimarães, Tiago M., Mara RC Guimarães, Ícaro AF Oliveira, Renata F. Leoni, Antonio C. Santos, Serdar M. Dursun, Jose AS Crippa et al. "Mononitrate Isosorbide as an Adjunctive Therapy in Schizophrenia: A Randomized Controlled Crossover Trial." Journal of Clinical Psychopharmacology 41, no. 3 (2021): 260-266. |
|
de Bartolomeis, Andrea, Livia Avvisati, Felice Iasevoli, and Carmine Tomasetti. "Intracellular pathways of antipsychotic combined therapies: implication for psychiatric disorders treatment." European journal of pharmacology 718, no. 1-3 (2013): 502-523. |
|
Davis, Michael C., and Stephen R. Marder. "Novel approaches for treating schizophrenia." Future Medicine Ltd, 2012. |
|
Roberts, Rosalinda C., Joy K. Roche, Shahza M. Somerville, and Robert R. Conley. "Ultrastructural Distinctions Between Treatment Responders and Non-Responders in Schizophrenia: Postmortem Studies of the Striatum." Mental Illnesses-Evaluation, Treatments and Implications. InTech (2011): 261-286. |
|
Aymen, Kachouchi, Zemrani Yassin, Ahroui Yassine, Salim Said, Berghalout Mohammed, Adali Imane, Manoudi Fatiha, Chabaa Laila, and Asri Fatima. "C-Reactive Protein and Aggression in Patients with Schizophrenia." International Journal of Psychological and Brain Sciences 4, no. 2 (2019): 7. |
|
Strzelecki, Dominik, and Jolanta Rabe-Jab?o?ska. "Zmiana w zakresie objawów pozytywnych, negatywnych oraz psychopatologii ogólnej u pacjentów ze schizofreni? otrzymuj?cych augmentacj? leczenia przeciwpsychotycznego glicyn?: wyniki wst?pnego 10-tygodniowego badania otwartego." Psychiatria Polska 45, no. 6 (2011): 825-837. |
|
Manu, Peter, Nilofar Sarvaiya, Liliana M. Rogozea, John M. Kane, and Christoph U. Correll. "Benign ethnic neutropenia and clozapine use: a systematic review of the evidence and treatment recommendations." The Journal of clinical psychiatry 77, no. 7 (2016): 0-0. |
|
Nooijen, Patty MM, Felix Carvalho, and Robert J. Flanagan. "Haematological toxicity of clozapine and some other drugs used in psychiatry." Human Psychopharmacology: Clinical and Experimental 26, no. 2 (2011): 112-119. |
|
Citrome, Leslie. "Treatment-resistant schizophrenia: what's next." Schizophrenia research 133, no. 1-3 (2011): 1-2. |
|
Occhieppo, Victoria Belén, Osvaldo Martín Basmadjian, Natalia Andrea Marchese, Anahí Rodríguez, Andrea Jaime, Malena Herrera, and Claudia Bregonzio. "Glial Cells in the Schizophrenia Puzzle: Angiotensin II Role." In Psychiatry and Neuroscience Update, pp. 169-181. Springer, Cham, 2021. |
|
Song, Cai, Yih-Shyuan Wu, Zhi-You Yang, Allan V. Kalueff, Yin-Yin Tsao, Yilong Dong, and Kuan-Pin Su. "Astrocyte-Conditioned Medium Protects Prefrontal Cortical Neurons from Glutamate-Induced Cell Death by Inhibiting TNF-? Expression." Neuroimmunomodulation 26, no. 1 (2019): 33-42. |
|
Jackson, Chris, Eleanor Baggott, Mark Bernard, Ruth Clutterbuck, Diane Ryles, and Erin Turner. Recovering from a first episode of psychosis: An integrated approach to early intervention. Routledge, 2019. |
|
Paribello, Pasquale, Mirko Manchia, Massimo Zedda, Federica Pinna, and Bernardo Carpiniello. "Leukocytosis Associated with Clozapine Treatment: A Case Series and Systematic Review of the Literature." Medicina 57, no. 8 (2021): 816. |
|
Sapkota, Kiran, Kim Dore, Kang Tang, Mark Irvine, Guangyu Fang, Erica S. Burnell, Roberto Malinow, David E. Jane, and Daniel T. Monaghan. "The NMDA receptor intracellular C-terminal domains reciprocally interact with allosteric modulators." Biochemical pharmacology 159 (2019): 140-153. |
|
I??k, Asl?han Özlem Polat, U?ur Çak?r, and Nermin Gündüz. "Leukocytosis after clozapine treatment in a patient with chronic schizophrenia." (2016). |
|
Klein, Corinna, and Anton Bespalov. "Development of novel therapy of schizophrenia in children and adolescents." Expert opinion on investigational drugs 23, no. 11 (2014): 1531-1540. |
|